子宫血管肉瘤2例报告并文献复习

doi:10.6040/j.issn.1671-7554.0.2022.0099

摘要/Abstract

摘要： 目的分析2例起初被误诊为其他类型子宫恶性肿瘤的子宫血管肉瘤病例并复习相关文献,以提高临床医生对其临床病理特征、治疗和预后的认识。方法收集并分析山东大学齐鲁医院妇科收治的2 例子宫血管肉瘤患者的临床资料,结合相关文献对该疾病进行总结。结果病例1接受了根治性手术,术后给予异环磷酰胺+表柔比星方案化疗6个周期,术后无进展生存期为62个月,总生存期为66个月;病例2接受了根治性手术,术后给予异环磷酰胺+表柔比星方案化疗4个周期,尚无复发迹象。结论子宫血管肉瘤临床上极为罕见,易被误诊,诊断时应借助病理及免疫组化与其他子宫恶性肿瘤相鉴别,手术联合术后辅助化疗可能是子宫血管肉瘤一种有效的治疗方法。

关键词: 血管肉瘤, 子宫恶性肿瘤, 误诊, 治疗, 预后

Abstract: Objective To analyze 2 cases of angiosarcoma of the uterus misdiagnosed as other types of uterine malignancies and to review relevant literature, so as to improve the clinicians awareness of the clinicopathological feature, treatment and prognosis of this disease. Methods The clinical data of 2 cases of uterine angiosarcoma were collected and analyzed, and relevant literature was reviewed. Results Case 1 received radical surgery and 6 cycles of ifosfamide + epirubicin chemotherapy after surgery. The postoperative progression-free survival was 62 months and the overall survival was 66 months. Case 2 received radical surgery and 4 cycles of ifosfamide + epirubicin chemotherapy, with no sign of recurrence. Conclusion Angiosarcoma of the uterus is extremely rare in clinical practice and is easily misdiagnosed. It should be differentiated from other uterine malignancies by pathology and immunohistochemistry. The combination of surgery and adjuvant chemotherapy might be effective.

Key words: Angiosarcoma, Uterine malignancy, Misdiagnosis, Therapy, Prognosis

中图分类号:

R737.33

王丽慧,高敏,孔北华. 子宫血管肉瘤2例报告并文献复习[J]. 山东大学学报 (医学版), 2022, 60(9): 108-112.

WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review[J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.

参考文献

[1] Young RJ, Brown NJ, Reed MW, et al. Angiosarcoma[J]. Lancet Oncol, 2010, 11(10): 983-991.
[2] Chinczewski L, Taube ET, Feldhaus FW, et al. Angiosarcomas of primary gynecologic origin—a case series and review of the literature[J]. Anticancer Res, 2020, 40(10): 5743-5750.
[3] Hara T, Miyoshi A, Kamei Y, et al. Epithelioid angiosarcoma arising from a huge leiomyoma: a case report and a literature review[J]. Case Rep Obstet Gynecol, 2018, 2018: 7591769. doi: 10.1155/2018/7591769.
[4] Chen TW, Burns J, Jones RL, et al. Optimal clinical management and the molecular biology of angiosarcomas[J]. Cancers(Basel), 2020, 12(11): 3321.
[5] Kruse A, Sep S, Slangen BFM, et al. Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival[J]. Int J Gynecol Cancer, 2014, 24(1): 4-12.
[6] Lahat G, Dhuka AR, Hallevi H, et al. Angiosarcoma: clinical and molecular insights[J]. Ann Surg, 2010, 251(6): 1098-1106.
[7] 熊云棋, 吴霞. 子宫上皮样血管肉瘤1例[J]. 实用妇产科杂志, 2015, 31(12): 938-939.
[8] Cao J, Wang J, He C, et al. Angiosarcoma: a review of diagnosis and current treatment[J]. Am J Cancer Res, 2019, 9(11): 2303-2313.
[9] Merfeld E, Gabani P, Spraker MB, et al. Clinical outcomes and prognostic features of angiosarcoma: significance of prior radiation therapy[J]. Clin Oncol(R Coll Radiol), 2019, 31(4): 232-241.
[10] Olawaiye AB, Morgan JA, Goodman A, et al. Epithelioid angiosarcoma of the uterus: a review of management[J]. Arch Gynecol Obstet, 2008, 278(5): 401-404.
[11] Hwang JP, Lim SM. Uterine epithelioid angiosarcoma on F-18 FDG PET/CT[J]. Nucl Med Mol Imaging, 2013, 47(2): 134-137.
[12] Soydal C, Kucuk ON, Gecim EI, et al. The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer[J]. Nucl Med Commun, 2013, 34(5): 501-506.
[13] 刘梅, 巴恩平, 赵坡, 等. 上皮样血管肉瘤的临床病理分析[J]. 中华病理学杂志, 2002, 31(5): 22-25. LIU Mei, BA Enping, ZHAO Po, et al. A clinicopathological study of fifteen epithelioid angiosarcoma[J]. Chinese Journal of Pathology, 2002, 31(5): 22-25.
[14] Liang D, Li L, He Y, et al. Primary uterine angiosarcoma: a case report in China with the literature review[J]. Indian J Pathol Microbiol, 2020, 63(Supplement): S94-S97.
[15] Sindhu S, Gimber LH, Cranmer L, et al. Angiosarcoma treated successfully with anti-PD-1 therapy—a case report[J]. J Immunother Cancer, 2017, 5(1): 58.
[16] Konishi Y, Sato H, Fujimoto T, et al. A case of primary uterine angiosarcoma: magnetic resonance imaging and computed tomography findings[J]. Int J Gynecol Cancer, 2007, 17(1): 280-284.

相关文章 15

[1]	吕艳锋丁克王建新禹化龙贝绍生. 慢性肛瘘癌变诊疗分析[J]. 山东大学学报(医学版), 2209, 47(6): 55-57.
[2]	巩性军，吴树明，张供，李守先，庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-.
[3]	孙红林,管玉强,于培儒,李磊,杜庆霞,丁浩. 支架植入治疗儿童主动脉缩窄并高血压的可行性及近中期疗效[J]. 山东大学学报 (医学版), 2026, 64(4): 58-62.
[4]	林明霞,刘桂斌,马燕花,连曌昱,任洋洋. ATP酶铜转运蛋白α介导的铜死亡途径及在肿瘤治疗中的价值[J]. 山东大学学报 (医学版), 2026, 64(4): 117-124.
[5]	樊呈敏,宋静雨,于书彦,毛雪琴. 舒肝解郁胶囊治疗青少年抑郁障碍的研究进展[J]. 山东大学学报 (医学版), 2026, 64(3): 17-23.
[6]	李雪凯,孙淋涵,刘端瑞,倪阳. 乳酸化修饰在肿瘤炎癌进程中的功能与机制研究进展[J]. 山东大学学报 (医学版), 2025, 63(9): 65-76.
[7]	李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[8]	刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[9]	王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[10]	贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[11]	国科,陈绪军,郑宝石,施超,黄克力,曹勇,陈军,吴东凯,张晓慎,罗俊辉,申林,莫绪明,杨岷,王晓武,雷印胜,田茂州,王振东,孟自力,孙忠东,李有金,陆辉辉,孟春营,高峰,陈黔苏,郭能瑞,柳德斌,张楠,林宇,陈文生,宋保国,方智,王海晨,廖晓波,徐朝军. 快通道拔管在全动脉冠脉旁路移植术的多中心临床效果[J]. 山东大学学报 (医学版), 2025, 63(5): 26-32.
[12]	杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[13]	杨卫芳,徐宏,刘元涛,赵蕙琛. 促甲状腺激素受体抗体在Graves病复发中的作用机制及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(4): 116-121.
[14]	赵芸慕兰,高海燕. 中、高危分化型甲状腺癌患者术后 ¹³¹I治疗反应及预后的影响因素[J]. 山东大学学报 (医学版), 2025, 63(2): 21-28.
[15]	刘文钊,张远,马湘萍,魏峰涛,卜培莉. 内皮活化和应激指数预测值与心力衰竭患者死亡风险的关联[J]. 山东大学学报 (医学版), 2025, 63(11): 27-35.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed